RLAY logo

RLAY
Relay Therapeutics Inc

1,194
Mkt Cap
$2.86B
Volume
1.97M
52W High
$17.32
52W Low
$2.67
PE Ratio
-9.38
RLAY Fundamentals
Price
$15.13
Prev Close
$15.09
Open
$15.17
50D MA
$11.45
Beta
1.84
Avg. Volume
2.6M
EPS (Annual)
-$1.61
P/B
4.64
Rev/Employee
$79,973.96
$929.56
Loading...
Loading...
News
all
press releases
Tudor Investment Corp ET AL Acquires New Shares in Relay Therapeutics, Inc. $RLAY
Tudor Investment Corp ET AL acquired a new stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year High - Should You Buy?
Relay Therapeutics (NASDAQ:RLAY) Reaches New 52-Week High - Time to Buy...
MarketBeat·10d ago
News Placeholder
JonesTrading Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY)
JonesTrading assumed coverage on Relay Therapeutics in a report on Tuesday. They set a "hold" rating and a $18.00 price objective on the stock...
MarketBeat·11d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) CFO Thomas Catinazzo Sells 1,800 Shares
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 1,800 shares of the company's stock in a transaction dated Thursday, April 9th. The stock was sold at an average price of $15.00, for a total value of $27,000.00. Following the completion of the sale, the chief...
MarketBeat·15d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) CFO Sells $230,498.17 in Stock
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 17,717 shares of Relay Therapeutics stock in a transaction dated Tuesday, April 7th. The shares were sold at an...
MarketBeat·16d ago
News Placeholder
Thomas Catinazzo Sells 1,800 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 1,800 shares of Relay Therapeutics stock in a transaction dated Thursday, April 9th. The shares were sold at an...
MarketBeat·16d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Hits New 52-Week High on Analyst Upgrade
Relay Therapeutics (NASDAQ:RLAY) Reaches New 12-Month High After Analyst Upgrade...
MarketBeat·16d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Given New $21.00 Price Target at Barclays
Barclays lifted their price objective on shares of Relay Therapeutics from $17.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday...
MarketBeat·17d ago
News Placeholder
JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. $RLAY
JPMorgan Chase & Co. cut its holdings in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Free Report) by 89.3% during the 3rd quarter, according to its most recent Form 13F filing with the...
MarketBeat·18d ago
News Placeholder
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?
Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·19d ago
<
1
2
...
>

Latest RLAY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.